Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 39 out of 100. Brain tissue and pathology

Topic: Brain proteins, microglia and lab models

Several reports confirmed possible inadvertent iatrogenic intracranial transmission of Aβ pathology via medical and surgical procedures (1,2).A common molecular mechanism, described in prion diseases, is proposed to trigger the replication and spread of different misfolded proteins in the central nervous system (CNS), causing different neurodegenerative diseases associated with disease-specific proteins such as α-synuclein in Parkinson's disease, and amyloid-beta (Aβ) in Alzheimer's disease, and cerebral amyloid angiopathy (CAA) (3). Medical procedures involving exposure to Aβ beyond childhood have been associated with possible iCAA in elderly patients (19). The growing literature on iCAA raises critical, medico-legal, and ethical questions-particularly regarding organ and tissue donor programs-and disclosure of diagnosis in clinical practice due to uncertainty about iCAA etiology, prognosis, and lack of treatments.This opinion argues for an increased clinical, medico-legal, and ethical awareness of iCAA in younger patients presenting with atypical ICH.Growing literature suggests that misfolded proteins, specifically Aβ, can be transmitted from person to person in a prion-like propagation through various medical and neurosurgical procedures. The appearance of Aβ seeding in the cerebral blood vessels a few decades after neurosurgical interventions indicates probable vascular complications associated with iCAA, including ICH, perivascular inflammation, and cognitive impairment (2).Disclosing the possibility of iCAA to a patient with symptoms compatible with CAA and a history of relevant exposure to exogenous Aβ conforms to the informed consent principle and is a prerequisite for respecting the patient's autonomy (23). In iCAA, it opens up relevant ethical considerations since this diagnosis is often associated with a certain uncertainty (20).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Zupan, M., Splavski, B., & Frol, S. (2025). Iatrogenic cerebral proteinopathies—The dawn of transmissible neurodegeneration? The example of cerebral amyloid angiopathy. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1693566

Vancouver

Zupan M, Splavski B, Frol S. Iatrogenic cerebral proteinopathies—The dawn of transmissible neurodegeneration? The example of cerebral amyloid angiopathy. Frontiers in Neurology. 2025. doi:10.3389/fneur.2025.1693566. PMID: 41281549.

BibTeX

@article{zupan2025-41281549,
  author  = {Zupan, Matija and Splavski, Bruno and Frol, Senta},
  title   = {{Iatrogenic cerebral proteinopathies—The dawn of transmissible neurodegeneration? The example of cerebral amyloid angiopathy}},
  journal = {Frontiers in Neurology},
  year    = {2025},
  doi     = {10.3389/fneur.2025.1693566},
  pmid    = {41281549},
  url     = {https://doi.org/10.3389/fneur.2025.1693566}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This opinion piece discusses reports that misfolded amyloid-beta can be transmitted between people through certain medical and surgical procedures, in a prion-like way, potentially causing cerebral amyloid angiopathy decades later. It argues for greater clinical, legal, and ethical awareness of this possibility, especially in younger patients with atypical brain hemorrhage.

Study details

How this study scored 39/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 39 of 100.39 of 100 points earned61 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Neurology)
Journal's citation record 2 / 4 Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 125 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Senta Frol: h-index 11 (OpenAlex, whole career)
Institution's track record 0 / 3 University of Ljubljana: institution h-index 544 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 4 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41281549)
Free to read 2 / 2 Free to read
Total 39 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Brain tissue and pathology

Also tagged “precursor”

1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Brain tissue and pathology

See all studies in Brain tissue and pathology →